4//SEC Filing
Fordham Benjamin C 4
Accession 0001209191-21-016003
CIK 0001108109other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:33 PM ET
Size
22.7 KB
Accession
0001209191-21-016003
Insider Transaction Report
Form 4
Fordham Benjamin C
EVP and General Counsel
Transactions
- Tax Payment
Common Stock
2021-03-01$8.81/sh−39,025$343,810→ 254,608 total - Award
Performance Based Restricted
2021-03-01+52,500→ 52,500 totalExercise: $0.00→ Common Stock (52,500 underlying) - Exercise/Conversion
Common Stock
2021-03-01+70,000→ 267,383 total - Award
Common Stock
2021-03-01+26,250→ 293,633 total - Exercise/Conversion
Performance Based Restricted
2021-03-01−35,000→ 0 totalExercise: $0.00→ Common Stock (35,000 underlying) - Award
Stock Options (Right to Buy)
2021-03-01+26,250→ 26,250 totalExercise: $8.81From: 2022-03-01Exp: 2031-02-28→ Common Stock (26,250 underlying)
Holdings
- 26,250
Stock Options (Right to Buy)
Exercise: $4.99From: 2020-03-01Exp: 2029-02-28→ Common Stock (26,250 underlying) - 26,250
Stock Options (Right to Buy)
Exercise: $4.93From: 2021-03-01Exp: 2030-02-28→ Common Stock (26,250 underlying) - 52,500
Performance Based Restricted
Exercise: $0.00→ Common Stock (52,500 underlying) - 52,500
Performance Based Restricted
Exercise: $0.00→ Common Stock (52,500 underlying)
Footnotes (6)
- [F1]The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2018-2020 Performance Period, the award vested on March 1, 2021 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/2/2018.
- [F2]The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
- [F3]The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2021-2023 Performance Period.
- [F4]Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
- [F5]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period.
- [F6]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period.
Documents
Issuer
COMMUNITY HEALTH SYSTEMS INC
CIK 0001108109
Entity typeother
Related Parties
1- filerCIK 0001700942
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:33 PM ET
- Size
- 22.7 KB